New item Free shipping Pay Now
Add this item to Cart for a combined free shipping deal
Click to enlarge photo

Listing Detail Tabs

This item has FREE SHIPPING to any address in NZ

NOTE: Item will ship from our US warehouse. A handling time of 2-4 business days applies for all orders. Delivery will then take 3-10 working days.

Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research

Condition: BRAND NEW
ISBN: 9781461452591
Author(s):
Format: Hardcover
Year: 2012
Edition: 12201st
Publisher: Springer
Dimensions: 157 x 234 x 23 (w x l x h)
Pages: 290

BUYER OFFERS: We are a retail store with set pricing and unfortunately we can't fulfil any requests to sell items for less than the listed price.

Description:
Despite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. Two major advances are making this goal possible. First, recent advances in genomics and proteomics in MM have allowed for increased understanding of disease pathogenesis, identified novel therapeutic targets, allowed for molecular classification, and provided the scientific rationale for combining targeted therapies to increase tumor cell cytotoxicity and abrogate drug resistance. Second, there is now an increased understanding of how adhesion of MM cells in bone marrow (BM) further impacts gene expression in MM cells, as well as in BM stromal cells (BMSCs).
As a result of these advances in oncogenomics on the one hand and increased understanding of the role of the BM in the pathogenesis of MM on the other, a new treatment paradigm targeting the tumor cell and its BM microenvironment to overcome drug resistance and improve patient outcome has now been developed. Thalidomide, lenalidomide, and Bortezomib are three Please click here to ask a question
Your question and answer privileges have been disabled.
You must log in to view questions and answers on this listing. We recommend reading questions before you make any purchases.
Please log in to view questions and answers on this listing. We recommend reading questions before you make any purchases. Available only to approved bidders. You must be an authenticated member to ask questions Find out more about becoming authenticated. Your account is in debt Your current account balance is You must credit your account to use this feature.
Firearms Licence #
By entering my licence number, I confirm I am aware of my obligations under the Arms Act.
Transaction details may be provided to police in accordance with the Terms & Conditions.
Your current account balance is Please note you will lose your question and answer privileges if your account is in debt for more than 2 weeks. Credit your account.
I confirm that I am over 18 years old.
To prevent your personal details being misused please do not put emails or phone numbers in questions. Failure to comply may result in the suspension of your account. The seller cannot add a Buy Now price once bidding has started.

Shipping options

  • Free shipping within New Zealand  
  • Store does not allow pick-ups
  • Store location: Auckland City, Auckland, NZ

Payment options

  • NZ bank deposit